European Best Practice Guidelines 14-16 -: Inadequate response to epoetin

被引:61
作者
Hörl, WH
Jacobs, C
Macdougall, IC
Valderrábano, F
Parrondo, I
Thompson, K
Carveth, BG
机构
关键词
D O I
10.1093/ndt/15.suppl_4.43
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:43 / 50
页数:8
相关论文
共 35 条
  • [11] Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?
    Cruz, DN
    Perazella, MA
    AbuAlfa, AK
    Mahnensmith, RL
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (04) : 535 - 540
  • [12] DHONDT AW, 1995, NEPHROL DIAL TRANSPL, V10, P2107
  • [13] Unresponsiveness to recombinant human erythropoietin in haemodialysis patients: Possible implications of angiotensin-converting enzyme inhibitors
    Erturk, S
    Ates, K
    Duman, N
    Karatan, O
    Erbay, B
    Ertug, E
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (02) : 396 - 397
  • [14] The impact of withdrawing ACE inhibitors on erythropoietin responsiveness and left ventricular hypertrophy in haemodialysis patients
    Ertürk, S
    Nergizoglu, G
    Ates, K
    Duman, N
    Erbay, B
    Karatan, O
    Ertug, AE
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (08) : 1912 - 1916
  • [15] RESISTANCE TO ERYTHROPOIETIN IN IRON-OVERLOADED HEMODIALYSIS-PATIENTS CAN BE OVERCOME BY ASCORBIC-ACID ADMINISTRATION
    GASTALDELLO, K
    VEREERSTRAETEN, A
    NZAMENZE, T
    VANHERWEGHEM, JL
    TIELEMANS, C
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 : 44 - 47
  • [16] Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients
    Goicoechea, M
    Vazquez, MI
    Ruiz, MA
    Gomez-Campdera, F
    Perez-Garcia, R
    Valderrábano, F
    [J]. NEPHRON, 1998, 78 (01): : 23 - 27
  • [17] Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients
    Gossmann, J
    Thurmann, P
    Bachmann, T
    Weller, S
    Kachel, HG
    Schoeppe, W
    Scheuermann, EH
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (03) : 973 - 978
  • [18] Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients?
    Hess, E
    Sperschneider, H
    Stein, G
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (04) : 749 - 751
  • [19] Is there a role for adjuvant therapy in patients being treated with epoetin?
    Hörl, WH
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 : 50 - 60
  • [20] Antioxidant status and lipid peroxidation in hemodialysis patients undergoing erythropoietin and erythropoietin-vitamin E combined therapy
    Inal, M
    Kanbak, G
    Sen, S
    Akyüz, F
    Sunal, E
    [J]. FREE RADICAL RESEARCH, 1999, 31 (03) : 211 - 216